During the equilibrium phase, some unstable dormant cancer cells in the TME survive the immunosurveillance and aided by upregulated epigenetic factor lysine (K)-demethylase 1B (KDM1B), the cytokines/interferons undergo epigenetic remodelling to yield protumorigenic IFN-1. Here, KDM1B is linked to cancer.